RxDoctor Payments Data

Brittany Buhalog, MD

Dermatology · Madison, WINPI 1720474513

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations.

$6,431in general payments, 2019–2025

Across 190 payments — averaging $33.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$803
  • AbbVie$765
  • Johnson & Johnson$676
  • Lilly USA, LLC$535
  • UCB, Inc.$401
  • E.r. Squibb & Sons, L.L.C.$393
  • plus $3K from 17 others

What the payments were for

  • Food & beverage$6,23697%
  • Education$1953%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,431 in reported general payments places this provider in the 85th percentile of 260 dermatology providers in Wisconsin.

See all dermatology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$993,884
Medicare patients
586
Services billed
3,108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin14$114
Mupirocin13$110
Doxycycline Hyclate13$46

Paid to pharmacies, not to this prescriber.

Other dermatology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →